These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21387762)

  • 21. [Overactive bladder in female and new strategy].
    Kubota Y; Sasaki S; Kojima Y; Hayase M; Kohri K
    Hinyokika Kiyo; 2007 Jun; 53(6):435-9. PubMed ID: 17628947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How do urodynamics findings influence the treatment of the typical patient with overactive bladder?
    Rutman MP; Cha DY; Blaivas JG
    Curr Urol Rep; 2012 Oct; 13(5):370-8. PubMed ID: 22843014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pediatric overactive bladder syndrome: pathophysiology and management.
    Franco I
    Paediatr Drugs; 2007; 9(6):379-90. PubMed ID: 18052408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urodynamic effects of the bladder C-fiber afferent activity modulation in chronic model of overactive bladder in rats.
    Juszczak K; Ziomber A; Wyczolkowski M; Thor PJ
    J Physiol Pharmacol; 2009 Dec; 60(4):85-91. PubMed ID: 20065501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical management of overactive bladder.
    Radomski SB; Barkin J
    Can J Urol; 2012 Oct; 19 Suppl 1():2-9. PubMed ID: 23089342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re: Overactive bladder: a better understanding of pathophysiology, diagnosis and management. A. J. Wein and R. R. Rackley J Urol, suppl., 2006; 175: S5-S10.
    Löfgren OE
    J Urol; 2007 Oct; 178(4 Pt 1):1553; author reply 1553. PubMed ID: 17707052
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical value of a patient-reported goal-attainment measure: the global development of self-assessment goal achievement (SAGA) questionnaire for patients with lower urinary tract symptoms.
    Khullar V; Espuna-Pons M; Marschall-Kehrel D; Fianu-Jonasson A; Kelleher CJ; Brubaker L; Beach J; Piault E; Trocio J
    Neurourol Urodyn; 2014 Jan; 33(1):90-4. PubMed ID: 23424173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining overactive bladder as hypersensitivity.
    Yamaguchi O; Honda K; Nomiya M; Shishido K; Kakizaki H; Tanaka H; Yamanishi T; Homma Y; Takeda M; Araki I; Obara K; Nishizawa O; Igawa Y; Goto M; Yokoyama O; Seki N; Takei M; Yoshida M
    Neurourol Urodyn; 2007 Oct; 26(6 Suppl):904-7. PubMed ID: 17663416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Causative significance of bladder blood flow in lower urinary tract symptoms.
    Matsumoto S; Kakizaki H
    Int J Urol; 2012 Jan; 19(1):20-5. PubMed ID: 22146061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urodynamic findings in female diabetic patients with and without overactive bladder symptoms.
    Ho CH; Tai HC; Yu HJ
    Neurourol Urodyn; 2010 Mar; 29(3):424-7. PubMed ID: 19283863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathophysiology of urinary incontinence, voiding dysfunction, and overactive bladder.
    Rahn DD; Roshanravan SM
    Obstet Gynecol Clin North Am; 2009 Sep; 36(3):463-74. PubMed ID: 19932410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Overactive bladder syndrome. How to manage it].
    Tanaka H; Mitsui T; Ameda K; Kobayashi S; Nonomura K
    Hokkaido Igaku Zasshi; 2009 Mar; 84(2):73-6. PubMed ID: 19364048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overactive bladder is not only overactive but also hypersensitive.
    Lee SR; Kim HJ; Kim A; Kim JH
    Urology; 2010 May; 75(5):1053-9. PubMed ID: 20092879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuromodulation for intractable OAB.
    Apostolidis A
    Neurourol Urodyn; 2011 Jun; 30(5):766-70. PubMed ID: 21661027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperosmolarity alters micturition: a comparison of urinary bladder motor activity in hyperosmolar and cyclophosphamide-induced models of overactive bladder.
    Juszczak K; Ziomber A; Wyczółkowski M; Thor PJ
    Can J Physiol Pharmacol; 2010 Sep; 88(9):899-906. PubMed ID: 20921976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of transcranial magnetotherapy on electroencephalographic parameters in females with overactive urinary bladder].
    Neĭmark AI; Klyzhina EA; Neĭmark BA; Mel'nik MA
    Urologiia; 2007; (5):40-4. PubMed ID: 18254224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overactive bladder in children. Part 1: Pathophysiology.
    Franco I
    J Urol; 2007 Sep; 178(3 Pt 1):761-8; discussion 768. PubMed ID: 17631323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overactive bladder: The importance of new guidance.
    Kirby M; Artibani W; Cardozo L; Chapple C; Diaz DC; De Ridder D; Espuna-Pons M; Haab F; Kelleher C; Milsom I; Van Kerrebroeck P; Vierhout M; Wagg A
    Int J Clin Pract; 2006 Oct; 60(10):1263-71. PubMed ID: 16981970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Place of overactive bladder in male lower urinary tract symptoms.
    Yamaguchi O; Aikawa K; Shishido K; Nomiya M
    World J Urol; 2009 Dec; 27(6):723-8. PubMed ID: 19705127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A practical primary care approach to overactive bladder.
    Rosenberg MT; Witt ES; Barkin J; Miner M
    Can J Urol; 2014 Jun; 21 Suppl 2():2-11. PubMed ID: 24978628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.